Cargando…

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells

BACKGROUND: There is accumulating evidence that propranolol, an antagonist of beta‐1 and beta‐2 adrenoreceptors, extends survival of patients with prostate cancer; yet it is not known whether propranolol inhibits beta‐adrenergic signaling in prostate cancer cells, or systemic effects of propranolol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alaskar, Aljoharah, Abdulraqeb Ali, Amaal, Hassan, Sazzad, Shinwari, Zakia, Alaiya, Ayodele, von Holzen, Urs, Miller, Lance, Kulik, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100053/ https://www.ncbi.nlm.nih.gov/pubmed/36373761 http://dx.doi.org/10.1002/pros.24455

Ejemplares similares

Proteomic Profiling of the First Human Dental Pulp Mesenchymal Stem/Stromal Cells from Carbonic Anhydrase II Deficiency Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2020)

Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study
por: AlZahrani, Shahd, et al.
Publicado: (2022)

Sex-Biased Expression of Genes Allocated in the Autosomal Chromosomes: Blood LC-MS/MS Protein Profiling in Healthy Subjects
por: Giha, Hayder A., et al.
Publicado: (2023)

LC-MS/MS proteomic analysis revealed novel associations of 37 proteins with T2DM and notable upregulation of immunoglobulins
por: Abdulwahab, Rabab Asghar, et al.
Publicado: (2019)

The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum
por: Alsemari, Abdulaziz, et al.
Publicado: (2014)

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2022)

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
por: Hassan, Md Sazzad, et al.
Publicado: (2023)

Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy
por: Colak, Dilek, et al.
Publicado: (2016)

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
por: Zhang, Joshua, et al.
Publicado: (2023)

Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis
por: McKee, Chad, et al.
Publicado: (2013)

Beta-Adrenoceptor Blocking Drugs and the Elderly
por: Wilkins, M. R., et al.
Publicado: (1984)

Uses of Beta-Adrenoceptor Blocking Drugs
por: Prichard, B. N. C., et al.
Publicado: (1976)

A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2017)

Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment
por: Malkawi, Abeer K., et al.
Publicado: (2019)

Slow Release Beta Adrenoceptor Blocking Drugs
por: Harron, D. W. G., et al.
Publicado: (1983)

Treatment of Hypertension with Beta-Adrenoceptor Blocking Drugs
por: Bai, Tony R., et al.
Publicado: (1982)

Are Selective Beta-Adrenoceptor Blocking Drugs an Advantage?
por: Kendall, M.J.
Publicado: (1981)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
por: Hassan, Md. Sazzad, et al.
Publicado: (2019)

Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation
por: Makhlouf, Zinb, et al.
Publicado: (2023)

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
por: Al-Moghrabi, Nisreen, et al.
Publicado: (2014)

Roles of Beta2- and Beta3-Adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome
por: Masuo, Kazuko
Publicado: (2010)

Signaling Pathways That Control Apoptosis in Prostate Cancer
por: Ali, Amaal, et al.
Publicado: (2021)

Beta-adrenoceptor regulates miRNA expression in rat heart
por: Hou, Yunlong, et al.
Publicado: (2012)

Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in Rat
por: Merlet, Nolwenn, et al.
Publicado: (2013)

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Propranolol exhibits activity against hemangiomas independent of beta blockade
por: Sasaki, Maiko, et al.
Publicado: (2019)

Differential marker expression by cultures rich in mesenchymal stem cells
por: Wetzig, Andrew, et al.
Publicado: (2013)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya, Ayodele, et al.
Publicado: (2021)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2021)

Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
por: Igawa, Yasuhiko, et al.
Publicado: (2010)

Gold-Nanoparticle Hybrid Nanostructures for Multimodal Cancer Therapy
por: Ali, Amaal Abdulraqeb, et al.
Publicado: (2022)

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
por: Wolter, Jennifer K, et al.
Publicado: (2013)

Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients
por: Alaiya, Ayodele A., et al.
Publicado: (2016)

Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
por: Bardou, Marc, et al.
Publicado: (2007)

Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation
por: Nia, Amir M., et al.
Publicado: (2010)

Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women
por: Liang, Ching-Chung, et al.
Publicado: (2023)

Surgical Stress Delays Prostate Involution in Mice
por: Hassan, Sazzad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ouohspla4oivijolbsvph20p6u